Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-in-human clinical trial of allogeneic, platelet-derived extracellular vesicles as a potential therapeutic for delayed wound healing.
Johnson J, Law SQK, Shojaee M, Hall AS, Bhuiyan S, Lim MBL, Silva A, Kong KJW, Schoppet M, Blyth C, Ranasinghe HN, Sejic N, Chuei MJ, Tatford OC, Cifuentes-Rius A, James PF, Tester A, Dixon I, Lichtfuss G. Johnson J, et al. Among authors: dixon i. J Extracell Vesicles. 2023 Jul;12(7):e12332. doi: 10.1002/jev2.12332. J Extracell Vesicles. 2023. PMID: 37353884 Free PMC article. Clinical Trial.
The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
Wood A, Emery JD, Jenkins M, Chondros P, Campbell T, Wenkart E, O'Reilly C, Cowie T, Dixon I, Toner J, Khalajzadeh H, Gutierrez JM, Govan L, Buckle G, McIntosh JG. Wood A, et al. Among authors: dixon i. Trials. 2022 Jan 12;23(1):31. doi: 10.1186/s13063-021-05877-3. Trials. 2022. PMID: 35022080 Free PMC article. Clinical Trial.
SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
McIntosh JG, Emery JD, Wood A, Chondros P, Goodwin BC, Trevena J, Wilson C, Chang S, Hocking J, Campbell T, Macrae F, Milley K, Lew JB, Nightingale C, Dixon I, Castelli M, Lee N, Innes L, Jolley T, Fletcher S, Buchanan L, Doncovio S, Broun K, Austin G, Jiang J, Jenkins MA. McIntosh JG, et al. Among authors: dixon i. Trials. 2023 Nov 13;24(1):723. doi: 10.1186/s13063-023-07756-5. Trials. 2023. PMID: 37957680 Free PMC article.
Scleraxis and fibrosis in the pressure-overloaded heart.
Nagalingam RS, Chattopadhyaya S, Al-Hattab DS, Cheung DYC, Schwartz LY, Jana S, Aroutiounova N, Ledingham DA, Moffatt TL, Landry NM, Bagchi RA, Dixon IMC, Wigle JT, Oudit GY, Kassiri Z, Jassal DS, Czubryt MP. Nagalingam RS, et al. Among authors: dixon imc. Eur Heart J. 2022 Dec 1;43(45):4739-4750. doi: 10.1093/eurheartj/ehac362. Eur Heart J. 2022. PMID: 36200607
Misoprostol treatment prevents hypoxia-induced cardiac dysfunction through a 14-3-3 and PKA regulatory motif on Bnip3.
Martens MD, Seshadri N, Nguyen L, Chapman D, Henson ES, Xiang B, Falk L, Mendoza A, Rattan S, Field JT, Kawalec P, Gibson SB, Keijzer R, Saleem A, Hatch GM, Doucette CA, Karch JM, Dolinsky VW, Dixon IM, West AR, Rampitsch C, Gordon JW. Martens MD, et al. Among authors: dixon im. Cell Death Dis. 2021 Nov 26;12(12):1105. doi: 10.1038/s41419-021-04402-3. Cell Death Dis. 2021. PMID: 34824192 Free PMC article.
153 results